KTTA - Pasithea Therapeutics Corp
Previous close
4.7104
0 0%
Share volume: 942
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.71
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-16 | 2022-08-15 | 2022-11-14 | 2023-03-30 | 2023-05-12 | 2023-08-11 | 2023-11-13 | |
| Cash flow financing | 0.000 | 0.000 | 0.000 | -3.206 M | 264.103 K | -130.768 K | -3.860 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -2.527 M | -2.377 M | -5.239 M | -4.419 M | -3.202 M | -3.080 M | -3.238 M | |
| Net income | -1.574 M | -2.658 M | -4.586 M | -5.118 M | -3.538 M | -3.763 M | -3.613 M | |
| Depreciation | 5.014 K | 10.787 K | 16.670 K | -97.000 | 161.720 K | 162.257 K | 162.256 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 302.132 K | 15.782 K | 122.500 K | 95.000 K | |
| Investing Cashflow | -113.867 K | 38.750 K | -230.429 K | -1.756 M | -53.888 K | 24.392 K | 50.159 K | |
| Net Borrowings | -50.950 M | -48.155 M | -43.487 M | -32.848 M | -30.283 M | -27.355 M | -20.291 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -113.867 K | -38.310 K | -197.447 K | -1.789 M | -53.888 K | -3.108 K | 22.659 K | |
| Cash Change | 50.321 M | 47.940 M | 42.398 M | 33.147 M | 29.914 M | 26.648 M | 19.585 M |